Pharmacological Actions, Molecular Mechanisms, Pharmacokinetic Progressions, and Clinical Applications of Hydroxysafflor Yellow A in Antidiabetic Research
Hydroxysafflor yellow A (HSYA), a nutraceutical compound derived from safflower (Carthamus tinctorius), has been shown as an effective therapeutic agent in cardiovascular diseases, cancer, and diabetes. Our previous study showed that the effect of HSYA on high-glucose-induced podocyte injury is rela...
Saved in:
| Main Authors: | Xilan Zhang, Dayue Shen, Yating Feng, Yuanping Li, Hui Liao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2021-01-01
|
| Series: | Journal of Immunology Research |
| Online Access: | http://dx.doi.org/10.1155/2021/4560012 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Elucidation of the biosynthetic pathway of hydroxysafflor yellow A
by: Zi-Long Wang, et al.
Published: (2025-05-01) -
Hydroxysafflor yellow A: a natural pigment with potential anticancer therapeutic effect
by: Yuhan Wang, et al.
Published: (2025-01-01) -
Hydroxysafflor Yellow A modulation of metabolite networks and inhibition of JAK2/STAT1 pathway in sepsis
by: Bingbing Pan, et al.
Published: (2025-07-01) -
Hydroxysafflor yellow A for ischemic heart diseases: a systematic review and meta-analysis of animal experiments
by: Tianshi Mao, et al.
Published: (2025-04-01) -
Pharmacokinetics and drug-likeness of antidiabetic flavonoids: Molecular docking and DFT study.
by: Mamaru Bitew, et al.
Published: (2021-01-01)